This month we added three new case studies to the Best Practice Database. The case studies look at what went right and wrong in the launches of Effient, Gardasil and Onglyza and provide an array of insights around critical issues affecting new product launches in the current environment. These three case studies deliver best practices and lessons learned for a variety of functional areas, including: marketing, policy, strategy, new product planning, and medical affairs. We also published a new report this month on establishing policies/guidelines for Competitive Intelligence groups to reduce corporate risk. The four new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

Feel free to forward this email to colleagues interested in any of the topics below. If they would also like to receive this monthly alert, they need only sign-up here
 
Newly Added Research
 
Note that study report and document purchases can be credited toward a membership in the Best Practice Database (http://www.bestpracticedatabase.com/), where our latest research as well as hundreds of additional concise research documents and presentations can be accessed on-demand.

Best Practice Database Documents

• Onglyza Case Study: Lack of Differentiation Mutes a Launch (ID 5109)
• Gardasil Case Study: Using Policy as a Springboard for Launch Success (ID 5108)
• Effient Case Study: Stumbling When Taking on the Market Leader (ID 5107)

• Best Practices in Competitive Intelligence: Policies & Guidelines that Reduce Corporate Risks (PSM-260)